MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
2.000
-0.020 (-0.99%)
At close: Jan 17, 2025, 4:00 PM
1.990
-0.010 (-0.49%)
After-hours: Jan 17, 2025, 7:52 PM EST
MAIA Biotechnology Employees
MAIA Biotechnology had 13 employees as of December 31, 2023. The number of employees decreased by 5 or -27.78% compared to the previous year.
Employees
13
Change (1Y)
-5
Growth (1Y)
-27.78%
Revenue / Employee
n/a
Profits / Employee
-$1,995,337
Market Cap
50.66M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 13 | -5 | -27.78% |
Dec 31, 2022 | 18 | 9 | 100.00% |
Dec 31, 2021 | 9 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
MAIA News
- 10 days ago - MAIA Biotechnology to Present at Biotech Showcase 2025 - Business Wire
- 4 weeks ago - MAIA Biotechnology Announces Director Participation in Recent Private Placement Closings - Business Wire
- 5 weeks ago - MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas - Business Wire
- 6 weeks ago - MAIA Biotechnology Announces Private Placement of Approximately $950,000 - Business Wire
- 7 weeks ago - MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer - Business Wire
- 2 months ago - MAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private Placement - Business Wire
- 2 months ago - MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting - Business Wire
- 3 months ago - MAIA Biotechnology Announces $2.44 Million Private Placement - Business Wire